Cordyceps Sunshine Biotech Holdings (RAJAF) Total Debt (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Total Debt history runs 6 years deep, the most recent figure standing at $465233.0 for Q4 2025.

• In Q4 2025, Total Debt rose 3.81% year-over-year to $465233.0; the TTM figure through Dec 2025 stood at $465233.0 (up 3.81% YoY), while the FY2025 annual figure was $465233.0, up 3.81% from the prior year.
• Total Debt was $465233.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $448155.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $2.0 million in Q4 2021 to a low of $414000.0 in Q3 2023.
• Historically, Total Debt has averaged $761958.5 across 5 years, with a median of $456694.0 in 2024.
• The sharpest annual moves came in 2021 and 2022: Total Debt climbed 16.81% in 2021, then sank 58.29% in 2022.
• A 5-year view of Total Debt shows it stood at $2.0 million in 2021, then tumbled by 58.29% to $828000.0 in 2022, then sank by 47.94% to $431079.0 in 2023, then advanced by 3.96% to $448155.0 in 2024, then gained by 3.81% to $465233.0 in 2025.
• The last three Total Debt figures came in at $465233.0 (Q4 2025), $448155.0 (Q4 2024), and $431079.0 (Q4 2023), per Business Quant data.